Clinical Trial Update: MCT8 Deficiency Caregiver Study

View source ↗

Summary

This clinical trial update indicates that the caregiver study for Monocarboxylate Transporter 8 (MCT8) deficiency/Allan-Herndon-Dudley Syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allan-herndon-dudley Syndrome
• Monocarboxylate Transporter Deficiency

Snippet

Sponsor: Rare Thyroid Therapeutics International AB | Conditions: Monocarboxylate Transporter 8 (MCT8) Deficiency, Allan-Herndon-Dudley Syndrome | Status: COMPLETED